Diabetes drug may hold potential as treatment for epilepsy

Apr 09, 2008

Metformine, a widely used diabetic drug, might also be an effective and safe therapy for epilepsy, researchers report. This new approach may be especially helpful for the subset of patients who have recurrent seizures despite therapy with the best available drugs.

The basis for metformine’s effect is similar to a ketogenic diet, which is an attempt to minimize dietary starch and sugar. Epilepsy patients have been using this severe dietary approach for centuries, which led Dr. Avtar Roopra and colleagues to wonder if drugs could tap into metabolic pathways and produce similar results.

The researchers identified a small molecule in neurons that senses how much energy is available on hand. Glucose normally turns on this sensor, but so does Metformine, a drug used to control blood sugar. By administering the proper dose, they could suppress over-active nerve cells by removing their ability to turn sugar into excess energy.

Roopra and colleagues now hope to apply their preliminary results to a mouse model of epilepsy.

Source: American Society for Biochemistry and Molecular Biology

Explore further: Japan first nation to approve Novartis psoriasis drug

add to favorites email to friend print save as pdf

Related Stories

Emergent behavior lets bubbles 'sense' environment

Oct 27, 2014

Tiny, soapy bubbles can reorganize their membranes to let material flow in and out in response to the surrounding environment, according to new work carried out in an international collaboration by biomedical ...

Playing tag with sugars in the cornfield

Sep 25, 2014

Sugars are usually known as energy storage units in plants and the insects that feed on them. But, sugars may also be part of a deadly game of tag between plant and insect according to scientists at the Max ...

Microalgae – the factories of the future

Sep 09, 2014

Biology professor Ralf Kaldenhoff is making microalgae fit for industry. The microorganisms could produce a variety of products from carbon dioxide and light.

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

Dec 22, 2014

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.